Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir.

Saved in:
Bibliographic Details
Title: Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir.
Authors: Bai, Francesca1 (AUTHOR) francesca.bai@asst-santipaolocarlo.it, Beringheli, Tomaso1 (AUTHOR), Vitaletti, Virginia1 (AUTHOR), Santoro, Andrea1 (AUTHOR), Molà, Francesco1 (AUTHOR), Copes, Alessandro1 (AUTHOR), Gemignani, Nicole1 (AUTHOR), Pettenuzzo, Sofia1 (AUTHOR), Castoldi, Roberto1 (AUTHOR), Varisco, Benedetta1 (AUTHOR), Nardo, Riccardo1 (AUTHOR), Lundgren, Lorenzo Brando1 (AUTHOR), Ligresti, Riccardo1 (AUTHOR), Sala, Matteo1 (AUTHOR), Albertini, Lorenzo1 (AUTHOR), Augello, Matteo1 (AUTHOR), Biasioli, Lorenzo1 (AUTHOR), Bono, Valeria1 (AUTHOR), Rovito, Roberta1 (AUTHOR), Bini, Teresa1 (AUTHOR)
Source: Infectious Diseases & Therapy. Jul2024, Vol. 13 Issue 7, p1589-1605. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938229
DOI:10.1007/s40121-024-00994-3